Hatsukami DK - Search Results

1

Reducing the relative value of cigarettes: Considerations for nicotine and non-nicotine factors.

White CM, Hatsukami DK, Donny EC. White CM, et al. Among authors: hatsukami dk. Neuropharmacology. 2020 Sep 15;175:108200. doi: 10.1016/j.neuropharm.2020.108200. Epub 2020 Jun 12. Neuropharmacology. 2020. PMID: 32535010 Free PMC article. Review.

2

Smoking topography and nicotine blood levels.

Hatsukami DK, Pickens RW, Svikis DS, Hughes JR. Hatsukami DK, et al. Addict Behav. 1988;13(1):91-5. doi: 10.1016/0306-4603(88)90031-7. Addict Behav. 1988. PMID: 3364230

3

Safety and immunogenicity of a nicotine conjugate vaccine in current smokers.

Hatsukami DK, Rennard S, Jorenby D, Fiore M, Koopmeiners J, de Vos A, Horwith G, Pentel PR. Hatsukami DK, et al. Clin Pharmacol Ther. 2005 Nov;78(5):456-67. doi: 10.1016/j.clpt.2005.08.007. Clin Pharmacol Ther. 2005. PMID: 16321612 Clinical Trial.

4

Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation.

Hatsukami DK, Kotlyar M, Hertsgaard LA, Zhang Y, Carmella SG, Jensen JA, Allen SS, Shields PG, Murphy SE, Stepanov I, Hecht SS. Hatsukami DK, et al. Addiction. 2010 Feb;105(2):343-55. doi: 10.1111/j.1360-0443.2009.02780.x. Addiction. 2010. PMID: 20078491 Free PMC article. Clinical Trial.

5

Nicotine reduction revisited: science and future directions.

Hatsukami DK, Perkins KA, Lesage MG, Ashley DL, Henningfield JE, Benowitz NL, Backinger CL, Zeller M. Hatsukami DK, et al. Tob Control. 2010 Oct;19(5):e1-10. doi: 10.1136/tc.2009.035584. Tob Control. 2010. PMID: 20876072 Free PMC article. Review.

6

Tobacco and nicotine product testing.

Hatsukami DK, Biener L, Leischow SJ, Zeller MR. Hatsukami DK, et al. Nicotine Tob Res. 2012 Jan;14(1):7-17. doi: 10.1093/ntr/ntr027. Epub 2011 Apr 2. Nicotine Tob Res. 2012. PMID: 21460383 Free PMC article. Review.

7

Nicotine reduction: strategic research plan.

Hatsukami DK, Benowitz NL, Donny E, Henningfield J, Zeller M. Hatsukami DK, et al. Nicotine Tob Res. 2013 Jun;15(6):1003-13. doi: 10.1093/ntr/nts214. Epub 2012 Oct 25. Nicotine Tob Res. 2013. PMID: 23100460 Free PMC article. Review.

8

Dose-response effects of spectrum research cigarettes.

Hatsukami DK, Heishman SJ, Vogel RI, Denlinger RL, Roper-Batker AN, Mackowick KM, Jensen J, Murphy SE, Thomas BF, Donny E. Hatsukami DK, et al. Nicotine Tob Res. 2013 Jun;15(6):1113-21. doi: 10.1093/ntr/nts247. Epub 2012 Nov 22. Nicotine Tob Res. 2013. PMID: 23178320 Free PMC article. Clinical Trial.

9

Very low nicotine content cigarettes and potential consequences on cardiovascular disease.

Joel DL, Denlinger RL, Dermody SS, Hatsukami DK, Benowitz NL, Donny EC. Joel DL, et al. Among authors: hatsukami dk. Curr Cardiovasc Risk Rep. 2012 Dec 1;6(6):534-541. doi: 10.1007/s12170-012-0266-9. Epub 2012 Sep 1. Curr Cardiovasc Risk Rep. 2012. PMID: 23264843 Free PMC article.

10

Ending tobacco-caused mortality and morbidity: the case for performance standards for tobacco products.

Hatsukami DK. Hatsukami DK. Tob Control. 2013 May;22 Suppl 1(Suppl 1):i36-7. doi: 10.1136/tobaccocontrol-2012-050785. Tob Control. 2013. PMID: 23591505 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

553 results

Search Page